Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Acute Blood Flow Restriction Walking on Immune Cell Phenotype and Function

Key facts

Where
Kelowna, CanadaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 19 and 64 years old?

Where in Canada

  • University of British Columbia OkanaganKelowna, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of British Columbia
Trial code
NCT07928531
Record updated
10 November 2026
Original description
To conduct a randomized control trial to determine the impact of acute blood flow restriction treadmill walking on immune cell counts, function, and phenotype in adults living with type 2 diabetes.Read full original descriptionShow less

Impact of Acute Blood Flow Restriction Walking on Immune Cell Phenotype and Function in Adults withT2D

To conduct a randomized control trial to determine the impact of acute blood flow restriction treadmill walking on immune cell counts, function, and phenotype in adults living with type 2 diabetes.

Inclusion: Aged 19-64 years; Diagnosed with type 2 diabetes with current HbA1c 5.7-9.0%; Completing <150 minutes of moderate-vigorous physical activity per week.

Exclusion: Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise; Unstable type 2 diabetes medication of the last 3 months; Absolute contraindications to BFR (i.e., peripheral vascular disease); A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions; A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis); Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely; Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity.

ClinicalTrials.gov NCT07928531